Item 2.02 - Results of Operations and Financial Condition: Cardinal Health, Inc. is reporting financial results and operational performance information as of August 11, 2026 Item 7.01 - Regulation FD Disclosure: The company is making additional disclosures under Regulation Fair Disclosure, indicating material information is being communicated to investors Item 9.01 - Financial Statements and…

Our analysis rates this filing BULLISH. Cardinal Health's FY2026 earnings release presents an exceptionally strong financial and operational picture with no material concerns. The company delivered a standout year characterized by: (1) robust revenue growth of 14% full-year with sustained Q4…

Concern level: LOW (1.2/10).

Notable risk changes: Strong Q4 FY2026 financial performance: Revenue $63.7B (+6% YoY), Non-GAAP diluted EPS $2.91 (+40% YoY), demonstrating operational momentum; Full-year FY2026 results exceeded expectations: Non-GAAP diluted EPS $11.26 (+37% YoY), all five operating segments achieved double-digit profit growth, indicating broad-based business strength; FY2027 guidance provided at 13-15% non-GAAP EPS growth…

The model predicts CAH will underperform the S&P 500 by about 0.0% over 30 days (model confidence 65%). This is model analysis for research, not investment advice.